BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1217948 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 6.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217949 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217950 Cc1nn(C)c2COC\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H30ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-7,9-11,13-15H,8,12,16-19H2,1-2H3,(H,37,38)/b6-5- RJDONMRZHDZWMR-WAYWQWQTSA-N 572148 (rac)-(11Z)-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,13,15-tetrahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 1::US11478451, Example 1 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572148&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591086 473133220 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217951 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217952 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217953 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217954 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217955 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217956 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217957 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 38.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217958 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 16000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217959 Cc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C32H32ClN3O4/c1-20-28-26(35(2)34-20)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) PPCSRTPOKGWSIX-UHFFFAOYSA-N 572149 US11447504, Example 2::US11447504, Example 3::US11447504, Example 4::US11478451, Example 4::rac-4-chloro-1,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572149&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591116 473133221 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217960 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217961 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217962 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217963 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217964 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217965 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 17.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217966 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217967 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) BPPSKYUYBHETDL-UHFFFAOYSA-N 572152 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 5::US11447504, Example 6::US11447504, Example 7::US11478451, Example 7 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572152&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591250 473133222 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217968 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217969 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217970 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217971 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217972 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 12.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217973 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217974 CCc1nn(CCN2CCOCC2)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C38H43ClN4O5/c1-2-31-35-32(43(40-31)18-17-41-19-23-46-24-20-41)25-47-21-6-5-16-42-36-29(14-15-30(39)34(35)36)28(37(42)38(44)45)12-8-22-48-33-13-7-10-26-9-3-4-11-27(26)33/h3-4,7,9-11,13-15H,2,5-6,8,12,16-25H2,1H3,(H,44,45) WDKPDJPIUJQOAB-UHFFFAOYSA-N 572157 4-chloro-3-ethyl-1-[2-(morpholin-4-yl)ethyl]-7-[3-(naphthalen-1-yloxy)propyl]-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 10::US11478451, Example 10 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572157&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591160 473133224 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217975 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572158 (rac)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 11::US11478451, Example 11 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572158&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133225 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217976 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572158 (rac)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 11::US11478451, Example 11 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572158&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133225 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217977 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H35ClN4O3/c1-21-29-27(35-37(21)3)20-36(2)17-6-7-18-38-31-25(15-16-26(34)30(29)31)24(32(38)33(39)40)13-9-19-41-28-14-8-11-22-10-4-5-12-23(22)28/h4-5,8,10-12,14-16H,6-7,9,13,17-20H2,1-3H3,(H,39,40) JFFOLBCOYWMQHS-UHFFFAOYSA-N 572158 (rac)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 11::US11478451, Example 11 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572158&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591225 473133225 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217978 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217979 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217980 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 26.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217981 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217982 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(35-34-20)19-36(2)16-5-6-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,34,35)(H,38,39) GELGKXVOWYYPCM-UHFFFAOYSA-N 572160 (−)-4-chloro-2,3,14-trimethyl-7-[3-(naphthalen-1-yloxy) propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 2)::US11447504, Example 13::US11478451, Example 13 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572160&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591720 473133227 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217983 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217984 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217985 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217986 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217987 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217988 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 5.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217989 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217990 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H31ClFN3O4/c1-19-28-26(35-36(19)2)18-40-15-4-3-14-37-30-24(12-13-25(33)29(28)30)23(31(37)32(38)39)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,38,39) NDWMVESOANHLBE-UHFFFAOYSA-N 572161 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 14::US11447504, Example 16::US11478451, Example 16 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572161&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591177 473133228 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217991 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217992 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H29ClFN3O4/c1-18-27-25(35-34-18)17-39-14-3-2-13-36-29-23(11-12-24(32)28(27)29)22(30(36)31(37)38)7-5-15-40-26-8-4-6-19-16-20(33)9-10-21(19)26/h4,6,8-12,16H,2-3,5,7,13-15,17H2,1H3,(H,34,35)(H,37,38) FZKJBLJEXASDNO-UHFFFAOYSA-N 572162 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 15::US11478451, Example 17 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572162&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591079 473133229 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217993 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1217994 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217995 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217996 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217997 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217998 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1217999 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218000 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 8.90 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218001 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218002 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClN3O4/c1-3-27-30-26(35-36(27)2)20-40-18-7-6-17-37-31-24(15-16-25(34)29(30)31)23(32(37)33(38)39)13-9-19-41-28-14-8-11-21-10-4-5-12-22(21)28/h4-5,8,10-12,14-16H,3,6-7,9,13,17-20H2,1-2H3,(H,38,39) COJURVSFEDLRNW-UHFFFAOYSA-N 572166 (rac)-4-chloro-3-ethyl-2-methyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 19::US11447504, Example 20::US11447504, Example 21::US11447504, Example 25::US11478451, Example 21 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 14000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572166&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591254 473133232 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218003 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218004 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218005 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218006 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218007 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218008 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218009 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218010 CCc1c-2c(CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H37ClN4O3/c1-4-28-31-27(36-38(28)3)21-37(2)18-7-8-19-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)14-10-20-42-29-15-9-12-22-11-5-6-13-23(22)29/h5-6,9,11-13,15-17H,4,7-8,10,14,18-21H2,1-3H3,(H,40,41) SMIRFHPIIHOGEQ-UHFFFAOYSA-N 572169 (rac)-4-chloro-3-ethyl-2,14-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 22::US11447504, Example 23::US11447504, Example 24::US11478451, Example 24 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572169&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591133 473133233 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218011 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H32ClN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) YJACXUAPNWODLN-UHFFFAOYSA-N 577624 (rac)-4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 25 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577624&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591216 474499800 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218012 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H32ClN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) YJACXUAPNWODLN-UHFFFAOYSA-N 577624 (rac)-4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 25 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577624&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591216 474499800 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218013 Cc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H32ClN3O4/c1-20-28-26(34-35(20)2)19-39-17-6-5-16-36-30-24(14-15-25(33)29(28)30)23(31(36)32(37)38)12-8-18-40-27-13-7-10-21-9-3-4-11-22(21)27/h3-4,7,9-11,13-15H,5-6,8,12,16-19H2,1-2H3,(H,37,38) YJACXUAPNWODLN-UHFFFAOYSA-N 577624 (rac)-4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 25 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577624&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591216 474499800 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218014 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218015 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218016 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 18.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218017 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218018 Cc1[nH]nc2COCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C31H30ClN3O4/c1-19-27-25(34-33-19)18-38-16-5-4-15-35-29-23(13-14-24(32)28(27)29)22(30(35)31(36)37)11-7-17-39-26-12-6-9-20-8-2-3-10-21(20)26/h2-3,6,8-10,12-14H,4-5,7,11,15-18H2,1H3,(H,33,34)(H,36,37) STPZDEATQDDZCR-UHFFFAOYSA-N 572173 4-chloro-2,3-dimethyl-7-[3-(naphthalen-1-yloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo-[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 26::US11447504, Example 27::US11478451, Example 27 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572173&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591331 473133234 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218019 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218020 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218021 Cc1c-2c(CNCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C31H31ClN4O3/c1-19-27-25(34-35(19)2)18-33-15-7-16-36-29-23(13-14-24(32)28(27)29)22(30(36)31(37)38)11-6-17-39-26-12-5-9-20-8-3-4-10-21(20)26/h3-5,8-10,12-14,33H,6-7,11,15-18H2,1-2H3,(H,37,38) UQDUQFWHFLOCHG-UHFFFAOYSA-N 572175 (rac)-12-chloro-10,11-dimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid-Formic Acid Salt::US11447504, Example 28::US11478451, Example 28 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572175&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 155123531 473133235 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218022 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218023 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218024 CN1CCCn2c(C(O)=O)c(CCCOc3cccc4ccccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C32H33ClN4O3/c1-20-28-26(34-36(20)3)19-35(2)16-8-17-37-30-24(14-15-25(33)29(28)30)23(31(37)32(38)39)12-7-18-40-27-13-6-10-21-9-4-5-11-22(21)27/h4-6,9-11,13-15H,7-8,12,16-19H2,1-3H3,(H,38,39) AZNRUVYELMSHOT-UHFFFAOYSA-N 572176 (rac)-12-chloro-7,10,11-trimethyl-1-[3-(naphthalen-1-yloxy)propyl]-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic Acid::US11447504, Example 29::US11478451, Example 29 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572176&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591196 473133236 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218025 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H34ClFN4O3/c1-20-29-27(36-38(20)3)19-37(2)15-4-5-16-39-31-25(13-14-26(34)30(29)31)24(32(39)33(40)41)9-7-17-42-28-10-6-8-21-18-22(35)11-12-23(21)28/h6,8,10-14,18H,4-5,7,9,15-17,19H2,1-3H3,(H,40,41) OGHDOPFGJXKBFT-UHFFFAOYSA-N 572177 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 30::US11478451, Example 30 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572177&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591246 473133237 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218026 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)n(C)nc4C1)c23 InChI=1S/C33H34ClFN4O3/c1-20-29-27(36-38(20)3)19-37(2)15-4-5-16-39-31-25(13-14-26(34)30(29)31)24(32(39)33(40)41)9-7-17-42-28-10-6-8-21-18-22(35)11-12-23(21)28/h6,8,10-14,18H,4-5,7,9,15-17,19H2,1-3H3,(H,40,41) OGHDOPFGJXKBFT-UHFFFAOYSA-N 572177 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 30::US11478451, Example 30 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572177&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591246 473133237 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218027 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218028 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218029 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 26.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218030 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218031 CN1CCCCn2c(C(O)=O)c(CCCOc3cccc4cc(F)ccc34)c3ccc(Cl)c(-c4c(C)[nH]nc4C1)c23 InChI=1S/C32H32ClFN4O3/c1-19-28-26(36-35-19)18-37(2)14-3-4-15-38-30-24(12-13-25(33)29(28)30)23(31(38)32(39)40)8-6-16-41-27-9-5-7-20-17-21(34)10-11-22(20)27/h5,7,9-13,17H,3-4,6,8,14-16,18H2,1-2H3,(H,35,36)(H,39,40) MCNVWPUURUOIIZ-UHFFFAOYSA-N 572178 (+)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3,14-trimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid-N-ethylethanamine Salt (Enantiomer 1)::US11447504, Example 31::US11478451, Example 32 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572178&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591090 473133238 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218032 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218033 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 18000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218034 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218035 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218036 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218037 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 22.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218038 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 12000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218039 CCc1nn(C)c2COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) VDWYPXRLOOMXTJ-UHFFFAOYSA-N 572180 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1-methyl-1,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 33::US11478451, Example 35 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 16000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572180&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591268 473133240 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218040 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 17000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218041 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218042 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218043 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218044 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 16.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218045 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218046 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218047 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218048 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218049 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218050 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218051 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218052 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218053 CCc1nn(C)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C34H36ClFN4O3/c1-4-27-31-28(39(3)37-27)20-38(2)16-5-6-17-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)10-8-18-43-29-11-7-9-21-19-22(36)12-13-23(21)29/h7,9,11-15,19H,4-6,8,10,16-18,20H2,1-3H3,(H,41,42) LFUKYUNPOGFDAD-UHFFFAOYSA-N 572186 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-1,14-dimethyl-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 39::US11447504, Example 40::US11447504, Example 41::US11478451, Example 41 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572186&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591100 473133246 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218054 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 12.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218055 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218056 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218057 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 4.00 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218058 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218059 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218060 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218061 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218062 CCc1nn(CCN2CCOCC2)c2CN(C)C\C=C/Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H44ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-8,10-12,14-16H,3,9,13,17-26H2,1-2H3,(H,46,47)/b7-6- SJXJNUGYXIGETG-SREVYHEPSA-N 572189 (rac)-(11Z)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]-propyl}-10,13,14,15-tetrahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 42::US11447504, Example 43::US11447504, Example 44::US11478451, Example 44 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572189&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591324 473133247 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218063 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 41.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218064 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218065 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218066 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218067 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218068 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218069 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 44.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218070 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218071 CCc1nn(CCN2CCOCC2)c2CN(C)CCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C39H46ClN5O4/c1-3-32-36-33(45(41-32)20-19-43-21-24-48-25-22-43)26-42(2)17-6-7-18-44-37-30(15-16-31(40)35(36)37)29(38(44)39(46)47)13-9-23-49-34-14-8-11-27-10-4-5-12-28(27)34/h4-5,8,10-12,14-16H,3,6-7,9,13,17-26H2,1-2H3,(H,46,47) GHFRJMORTHPRRF-UHFFFAOYSA-N 572192 (rac)-4-chloro-3-ethyl-14-methyl-1-[2-(morpholin-4-yl)ethyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-1H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 45::US11447504, Example 46::US11447504, Example 47::US11478451, Example 47 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572192&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591276 473133248 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218072 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218073 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218074 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218075 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218076 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218077 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218078 CN1CCN(CCCn2nc3COCCCCn4c(C(O)=O)c(CCCOc5cccc6ccccc56)c5ccc(Cl)c(-c3c2C)c45)CC1 InChI=1S/C39H46ClN5O4/c1-27-35-33(41-45(27)19-9-17-43-22-20-42(2)21-23-43)26-48-24-6-5-18-44-37-31(15-16-32(40)36(35)37)30(38(44)39(46)47)13-8-25-49-34-14-7-11-28-10-3-4-12-29(28)34/h3-4,7,10-12,14-16H,5-6,8-9,13,17-26H2,1-2H3,(H,46,47) DQGMLLGNPCATLY-UHFFFAOYSA-N 572195 (rac)-4-chloro-3-methyl-2-[3-(4-methylpiperazin-1-yl)propyl]-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 48::US11478451, Example 50 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572195&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591098 473133249 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218079 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218080 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218081 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218082 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218083 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218084 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClN3O3/c1-3-28-31-27(36-37(28)2)16-6-4-5-9-20-38-32-25(18-19-26(35)30(31)32)24(33(38)34(39)40)15-11-21-41-29-17-10-13-22-12-7-8-14-23(22)29/h7-8,10,12-14,17-19H,3-6,9,11,15-16,20-21H2,1-2H3,(H,39,40) SSTSSUXFOIWKBG-UHFFFAOYSA-N 572198 (rac)-4-chloro-3-ethyl-2-methyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 51::US11478451, Example 52 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572198&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591134 473133252 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218085 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 21.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218086 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218087 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218088 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218089 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218090 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218091 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 7.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218092 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218093 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-18-32(34,35)14-15-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-16-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) BGHOHGRGKVVKET-UHFFFAOYSA-N 572203 4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine Salt—Enantiomer 1::US11447504, Example 56::US11447504, Example 57::US11478451, Example 57 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572203&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591179 473133257 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218094 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218095 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 19000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218096 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218097 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218098 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218099 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 23.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218100 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 16000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218101 Cc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClF4N4O3/c1-20-29-27(40-41(20)2)18-42(19-34(37,38)39)14-3-4-15-43-31-25(12-13-26(35)30(29)31)24(32(43)33(44)45)8-6-16-46-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17H,3-4,6,8,14-16,18-19H2,1-2H3,(H,44,45) RFZZMGINSPWQEQ-UHFFFAOYSA-N 572205 (rac)-4-chloro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,3-dimethyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 58::US11447504, Example 59::US11447504, Example 60::US11478451, Example 60 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572205&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591124 473133258 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218102 CCc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClF4N4O3/c1-3-28-31-27(41-42(28)2)19-43(20-35(38,39)40)15-4-5-16-44-32-25(13-14-26(36)30(31)32)24(33(44)34(45)46)9-7-17-47-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18H,3-5,7,9,15-17,19-20H2,1-2H3,(H,45,46) SOQSAVNRWHIOGH-UHFFFAOYSA-N 572208 (rac) 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 61::US11447504, Example 62::US11478451, Example 61 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572208&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591302 473133259 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218103 CCc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClF4N4O3/c1-3-28-31-27(41-42(28)2)19-43(20-35(38,39)40)15-4-5-16-44-32-25(13-14-26(36)30(31)32)24(33(44)34(45)46)9-7-17-47-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18H,3-5,7,9,15-17,19-20H2,1-2H3,(H,45,46) SOQSAVNRWHIOGH-UHFFFAOYSA-N 572208 (rac) 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 61::US11447504, Example 62::US11478451, Example 61 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572208&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591302 473133259 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218104 CCc1c-2c(CN(CC(F)(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClF4N4O3/c1-3-28-31-27(41-42(28)2)19-43(20-35(38,39)40)15-4-5-16-44-32-25(13-14-26(36)30(31)32)24(33(44)34(45)46)9-7-17-47-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18H,3-5,7,9,15-17,19-20H2,1-2H3,(H,45,46) SOQSAVNRWHIOGH-UHFFFAOYSA-N 572208 (rac) 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-(2,2,2-trifluoroethyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic Acid::US11447504, Example 61::US11447504, Example 62::US11478451, Example 61 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572208&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591302 473133259 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218105 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218106 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 19000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218107 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218108 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 50.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218109 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218110 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218111 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218112 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218113 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218114 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218115 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 19000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218116 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218117 Cc1c-2c(COCC(F)(F)C(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H28ClF4N3O4/c1-18-26-24(38-39(18)2)15-43-17-32(36,37)31(34,35)16-40-28-22(12-13-23(33)27(26)28)21(29(40)30(41)42)10-6-14-44-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,41,42) NCBOLFGZINPIFJ-UHFFFAOYSA-N 577663 (rac)-4-chloro-11,11,12,12-tetrafluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 67 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 22.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577663&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591337 474499839 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218118 Cc1c-2c(COCC(F)(F)C(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H28ClF4N3O4/c1-18-26-24(38-39(18)2)15-43-17-32(36,37)31(34,35)16-40-28-22(12-13-23(33)27(26)28)21(29(40)30(41)42)10-6-14-44-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,41,42) NCBOLFGZINPIFJ-UHFFFAOYSA-N 577663 (rac)-4-chloro-11,11,12,12-tetrafluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 67 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577663&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591337 474499839 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218119 Cc1c-2c(COCC(F)(F)C(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H28ClF4N3O4/c1-18-26-24(38-39(18)2)15-43-17-32(36,37)31(34,35)16-40-28-22(12-13-23(33)27(26)28)21(29(40)30(41)42)10-6-14-44-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,41,42) NCBOLFGZINPIFJ-UHFFFAOYSA-N 577663 (rac)-4-chloro-11,11,12,12-tetrafluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 67 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577663&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591337 474499839 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218120 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218121 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218122 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218123 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 4.90 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218124 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218125 CCc1c-2c(COCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)19-41-16-5-4-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18H,3-5,7,9,15-17,19H2,1-2H3,(H,39,40) DSRUJIWLAZNHGL-UHFFFAOYSA-N 572183 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 36::US11478451, Example 069 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572183&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591175 473133243 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218126 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218127 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218128 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 25.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218129 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218130 CCc1c-2c(CCCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H35ClFN3O3/c1-3-28-31-27(37-38(28)2)12-6-4-5-7-18-39-32-25(16-17-26(35)30(31)32)24(33(39)34(40)41)11-9-19-42-29-13-8-10-21-20-22(36)14-15-23(21)29/h8,10,13-17,20H,3-7,9,11-12,18-19H2,1-2H3,(H,40,41) OHARMQWZWCLEAS-UHFFFAOYSA-N 572201 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[4′,3′:4,5]azacycloundecino[3,2,1-hi]indole-8-carboxylic Acid::US11447504, Example 54::US11478451, Example 071 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572201&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591153 473133255 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218131 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.80 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218132 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218133 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218134 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 110 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218135 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218136 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218137 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218138 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClN3O4/c1-3-28-31-27(37-38(28)2)20-42-21-35(15-16-35)17-18-39-32-25(13-14-26(36)30(31)32)24(33(39)34(40)41)11-7-19-43-29-12-6-9-22-8-4-5-10-23(22)29/h4-6,8-10,12-14H,3,7,11,15-21H2,1-2H3,(H,40,41) LIPRSTXCRRUMBL-UHFFFAOYSA-N 577668 US11478451, Example 072::US11478451, Example 073::US11478451, Example 074 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577668&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591323 474499844 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218139 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218140 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218141 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218142 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218143 CCc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)19-42(20-30(38)39)15-4-5-16-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)9-7-17-46-29-10-6-8-21-18-22(37)11-12-23(21)29/h6,8,10-14,18,30H,3-5,7,9,15-17,19-20H2,1-2H3,(H,44,45) SKCPFJJDOFGWGO-UHFFFAOYSA-N 577659 (rac)-4-chloro-14-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 075::US11478451, Example 076::US11478451, Example 62 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577659&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591242 474499835 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218144 Cc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-20-30-27(39-40(20)2)18-41(19-29(37)38)14-3-4-15-42-32-25(12-13-26(35)31(30)32)24(33(42)34(43)44)8-6-16-45-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17,29H,3-4,6,8,14-16,18-19H2,1-2H3,(H,43,44) KZNKRINHHKLXHL-UHFFFAOYSA-N 577673 US11478451, Example 077 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 13.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577673&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591218 474499845 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218145 Cc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-20-30-27(39-40(20)2)18-41(19-29(37)38)14-3-4-15-42-32-25(12-13-26(35)31(30)32)24(33(42)34(43)44)8-6-16-45-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17,29H,3-4,6,8,14-16,18-19H2,1-2H3,(H,43,44) KZNKRINHHKLXHL-UHFFFAOYSA-N 577673 US11478451, Example 077 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577673&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591218 474499845 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218146 Cc1c-2c(CN(CC(F)F)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-20-30-27(39-40(20)2)18-41(19-29(37)38)14-3-4-15-42-32-25(12-13-26(35)31(30)32)24(33(42)34(43)44)8-6-16-45-28-9-5-7-21-17-22(36)10-11-23(21)28/h5,7,9-13,17,29H,3-4,6,8,14-16,18-19H2,1-2H3,(H,43,44) KZNKRINHHKLXHL-UHFFFAOYSA-N 577673 US11478451, Example 077 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577673&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591218 474499845 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218147 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218148 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 11000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218149 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218150 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218151 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 10000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218152 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218153 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218154 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218155 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218156 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 64.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218157 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218158 Cc1c-2c(COCC3CCC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClN3O4/c1-20-30-28(36-37(20)2)19-41-18-23-13-12-22(23)17-38-32-26(14-15-27(35)31(30)32)25(33(38)34(39)40)10-6-16-42-29-11-5-8-21-7-3-4-9-24(21)29/h3-5,7-9,11,14-15,22-23H,6,10,12-13,16-19H2,1-2H3,(H,39,40) UXSFIMYRQOIGPQ-UHFFFAOYSA-N 572210 (9aS,11 aR)-3-chloro-4,5-dimethyl-15-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9,9a, 10,11,11a, 12-octahydrocyclobuta[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-14-carboxylic Acid—Stereoisomer 1::US11447504, Example 63::US11447504, Example 64::US11478451, Example 081 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572210&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591248 473133260 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218159 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218160 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 18000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218161 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218162 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 17000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218163 Cc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H32ClN3O4/c1-19-29-27(35-36(19)2)18-40-17-22-15-21(22)16-37-31-25(12-13-26(34)30(29)31)24(32(37)33(38)39)10-6-14-41-28-11-5-8-20-7-3-4-9-23(20)28/h3-5,7-9,11-13,21-22H,6,10,14-18H2,1-2H3,(H,38,39) NAMHEZLSLWIGJK-UHFFFAOYSA-N 572212 (9aS,10aR or 9aR, 10aS)-3-chloro-4,5-dimethyl-14-{3-[(naphthalen-1-yl)oxy]propyl}-5,7,9a, 10,10a, 11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino-[8,7,6-hi]indole-13-carboxylic Acid—Stereoisomer 1::US11447504, Example 65::US11447504, Example 66::US11478451, Example 083 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572212&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591299 473133261 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218164 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 52.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218165 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 14000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218166 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218167 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218168 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218169 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218170 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218171 CCc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-18-33(36,37)13-14-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-15-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) RVPQOBYZHGHWNE-UHFFFAOYSA-N 572202 (rac)-4-chloro-12,12-difluoro-2,3-dimethyl-7-{3-[(naphthalen-1-yl)oxy]propyl}-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic Acid::US11447504, Example 55::US11478451, Example 086 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=572202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=572202&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591253 473133256 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218172 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 12000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218173 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218174 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 13.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218175 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 9000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218176 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 16000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218177 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 10.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218178 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 18000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218179 Cc1c-2c(COCCn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C30H28ClN3O4/c1-18-26-24(32-33(18)2)17-37-16-14-34-28-22(12-13-23(31)27(26)28)21(29(34)30(35)36)10-6-15-38-25-11-5-8-19-7-3-4-9-20(19)25/h3-5,7-9,11-13H,6,10,14-17H2,1-2H3,(H,35,36) FQNIYAGBZSSXJR-UHFFFAOYSA-N 577683 US11478451, Example 087::US11478451, Example 088::US11478451, Example 089 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577683&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591313 474499854 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218180 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.50 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218181 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218182 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218183 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 24.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218184 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218185 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218186 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218187 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218188 Cc1c-2c(COCC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-17-32(35,36)12-13-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-14-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) YREPGHIIHZAQNE-UHFFFAOYSA-N 577686 US11478451, Example 090::US11478451, Example 091::US11478451, Example 092 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577686&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591107 474499855 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218189 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-14-12-32(35,36)17-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-13-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) AFVSXYQYLIGMBZ-UHFFFAOYSA-N 577689 US11478451, Example 093 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577689&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591229 474499856 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218190 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H29ClF3N3O4/c1-18-27-25(37-38(18)2)16-42-14-12-32(35,36)17-39-29-23(10-11-24(33)28(27)29)22(30(39)31(40)41)6-4-13-43-26-7-3-5-19-15-20(34)8-9-21(19)26/h3,5,7-11,15H,4,6,12-14,16-17H2,1-2H3,(H,40,41) AFVSXYQYLIGMBZ-UHFFFAOYSA-N 577689 US11478451, Example 093 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 18000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577689&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591229 474499856 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218191 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 11.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218192 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 13000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218193 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218194 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218195 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218196 Cc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5ccccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C32H30ClF2N3O4/c1-19-27-25(36-37(19)2)17-41-16-14-32(34,35)18-38-29-23(12-13-24(33)28(27)29)22(30(38)31(39)40)10-6-15-42-26-11-5-8-20-7-3-4-9-21(20)26/h3-5,7-9,11-13H,6,10,14-18H2,1-2H3,(H,39,40) OUQRKUSSDUUFLP-UHFFFAOYSA-N 577664 (rac)-4-chloro-11,11-difluoro-2,3-dimethyl-7-[3-(1-naphthyloxy)propyl]-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid::US11478451, Example 094::US11478451, Example 095::US11478451, Example 68 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577664&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591271 474499840 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218197 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218198 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 12000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218199 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 12000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218200 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218201 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 20.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218202 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 10000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218203 CCc1c-2c(COCCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H31ClF3N3O4/c1-3-26-29-25(38-39(26)2)17-43-15-13-33(36,37)18-40-30-23(11-12-24(34)28(29)30)22(31(40)32(41)42)7-5-14-44-27-8-4-6-19-16-20(35)9-10-21(19)27/h4,6,8-12,16H,3,5,7,13-15,17-18H2,1-2H3,(H,41,42) HRVSPZYJJJPUPB-UHFFFAOYSA-N 577692 US11478451, Example 096::US11478451, Example 097::US11478451, Example 098 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577692&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591096 474499857 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218204 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218205 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218206 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 6.90 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218207 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218208 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218209 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 11.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218210 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218211 CCc1c-2c(COCC(O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O5/c1-3-27-30-26(36-37(27)2)18-42-17-21(39)13-14-38-31-24(11-12-25(34)29(30)31)23(32(38)33(40)41)7-5-15-43-28-8-4-6-19-16-20(35)9-10-22(19)28/h4,6,8-12,16,21,39H,3,5,7,13-15,17-18H2,1-2H3,(H,40,41) PKDNZESWIQFBSN-UHFFFAOYSA-N 577695 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-12-hydroxy-2-methyl-2,10,11,12,13,15-hexahydropyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid-N-ethylethanamine salt (Stereoisomer 1)::US11478451, Example 101::US11478451, Example 102::US11478451, Example 99 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577695&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591259 474499858 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218212 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577698 (rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Racemante 1)::US11478451, Example 103 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 14000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577698&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499859 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218213 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577698 (rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Racemante 1)::US11478451, Example 103 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 18000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577698&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499859 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218214 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577699 (+)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 104 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577699&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499860 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218215 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577699 (+)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 104 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577699&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499860 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218216 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577699 (+)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 104 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577699&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499860 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218217 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577700 (−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid N-ethylethanamine salt (Enantiomer 2)::US11478451, Example 105 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 16000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577700&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499861 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218218 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577700 (−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid N-ethylethanamine salt (Enantiomer 2)::US11478451, Example 105 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577700&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499861 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218219 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577701 (rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Racemate 2)::US11478451, Example 106 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 5.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577701&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499862 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218220 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577701 (rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Racemate 2)::US11478451, Example 106 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 15000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577701&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499862 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218221 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577701 (rac)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Racemate 2)::US11478451, Example 106 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577701&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499862 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218222 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577702 (+)-(3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Enantiomer 3)::US11478451, Example 107 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577702&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499863 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218223 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577702 (+)-(3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Enantiomer 3)::US11478451, Example 107 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577702&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499863 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218224 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577703 (−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Enantiomer 4)::US11478451, Example 108 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 7.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577703&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499864 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218225 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577703 (−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Enantiomer 4)::US11478451, Example 108 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577703&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499864 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218226 CCc1c-2c(COCC3CC3Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H33ClFN3O4/c1-3-28-31-27(37-38(28)2)18-42-17-21-14-20(21)16-39-32-25(11-12-26(35)30(31)32)24(33(39)34(40)41)7-5-13-43-29-8-4-6-19-15-22(36)9-10-23(19)29/h4,6,8-12,15,20-21H,3,5,7,13-14,16-18H2,1-2H3,(H,40,41) NNIZSKXUZBQRNK-UHFFFAOYSA-N 577703 (−)-3-chloro-4-ethyl-14-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-5-methyl-5,7,9a,10,10a,11-hexahydro-9H-cyclopropa[3,4]pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-13-carboxylic acid (Enantiomer 4)::US11478451, Example 108 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577703&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591257 474499864 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218227 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577704 (rac)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid::US11478451, Example 109 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577704&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499865 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218228 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577704 (rac)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid::US11478451, Example 109 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577704&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499865 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218229 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577704 (rac)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid::US11478451, Example 109 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577704&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499865 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218230 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577705 (−)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid-N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 110 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 16000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577705&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499866 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218231 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577705 (−)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid-N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 110 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577705&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499866 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218232 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577706 (+)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid-N-ethylethanamine salt (Enantiomer 2)::US11478451, Example 111 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 19.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577706&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499867 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218233 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577706 (+)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid-N-ethylethanamine salt (Enantiomer 2)::US11478451, Example 111 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 16000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577706&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499867 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218234 CCc1c-2c(COCC3(CC3)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H35ClFN3O4/c1-3-28-31-27(38-39(28)2)19-43-20-35(13-14-35)15-16-40-32-25(11-12-26(36)30(31)32)24(33(40)34(41)42)7-5-17-44-29-8-4-6-21-18-22(37)9-10-23(21)29/h4,6,8-12,18H,3,5,7,13-17,19-20H2,1-2H3,(H,41,42) KVOJNOZDXGZAIE-UHFFFAOYSA-N 577706 (+)-4′-chloro-3′-ethyl-7′-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2′-methyl-2′,10′,11′,15′-tetrahydro-13′H-spiro[cyclopropane-1,12′-pyrazolo[4′,3′:9,10][1,6]oxazacycloundecino[8,7,6-hi]indole]-8′-carboxylic acid-N-ethylethanamine salt (Enantiomer 2)::US11478451, Example 111 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 18000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577706&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591314 474499867 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218235 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577707 (rac)-12-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid::US11478451, Example 112 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577707&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499868 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218236 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577707 (rac)-12-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid::US11478451, Example 112 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577707&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499868 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218237 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577707 (rac)-12-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid::US11478451, Example 112 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577707&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499868 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218238 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577708 (+)-12-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 113 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577708&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499869 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218239 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577708 (+)-12-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid N-ethylethanamine salt (Enantiomer 1)::US11478451, Example 113 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577708&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499869 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218240 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577709 (−)-2-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid salt (Enantiomer 2)::US11478451, Example 114 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 7.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577709&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499870 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218241 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577709 (−)-2-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid salt (Enantiomer 2)::US11478451, Example 114 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577709&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499870 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218242 CCc1c-2c(CN(C)CCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-4-27-30-26(36-38(27)3)19-37(2)15-7-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-6-17-42-28-10-5-8-20-18-21(35)11-12-22(20)28/h5,8,10-14,18H,4,6-7,9,15-17,19H2,1-3H3,(H,40,41) SBCOOYGIYRFUJP-UHFFFAOYSA-N 577709 (−)-2-chloro-11-ethyl-1-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-7,10-dimethyl-4,5,6,7,8,10-hexahydropyrazolo[3′,4′:7,8][1,5]diazecino[9,10,1-hi]indole-2-carboxylic acid salt (Enantiomer 2)::US11478451, Example 114 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577709&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591135 474499870 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218243 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577710 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 115 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577710&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499871 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218244 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577710 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 115 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577710&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499871 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218245 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577711 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 1)::US11478451, Example 116 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577711&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499872 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218246 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577711 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 1)::US11478451, Example 116 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577711&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499872 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218247 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577711 (+)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 1)::US11478451, Example 116 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577711&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499872 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218248 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577712 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 2)::US11478451, Example 117 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 6.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577712&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499873 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218249 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577712 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 2)::US11478451, Example 117 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577712&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499873 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218250 CCc1c-2c(CCCN(C)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H36ClFN4O3/c1-4-28-31-27(37-39(28)3)10-6-16-38(2)17-18-40-32-25(14-15-26(35)30(31)32)24(33(40)34(41)42)9-7-19-43-29-11-5-8-21-20-22(36)12-13-23(21)29/h5,8,11-15,20H,4,6-7,9-10,16-19H2,1-3H3,(H,41,42) FPOLKHIRETYZKM-UHFFFAOYSA-N 577712 (−)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,12-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 2)::US11478451, Example 117 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577712&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591284 474499873 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218251 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.30 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218252 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218253 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218254 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 39.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218255 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218256 CCc1c-2c(CCCN(CC(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C35H36ClF3N4O3/c1-3-28-32-27(40-41(28)2)9-5-15-42(20-30(38)39)16-17-43-33-25(13-14-26(36)31(32)33)24(34(43)35(44)45)8-6-18-46-29-10-4-7-21-19-22(37)11-12-23(21)29/h4,7,10-14,19,30H,3,5-6,8-9,15-18,20H2,1-2H3,(H,44,45) VIYPHNLFAISCNM-UHFFFAOYSA-N 577713 (rac)-4-chloro-12-(2,2-difluoroethyl)-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 118::US11478451, Example 120 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577713&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591239 474499874 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218257 CCc1c-2c(CCCN(CCCCOC(C)=O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C39H44ClFN4O5/c1-4-33-36-32(42-43(33)3)12-8-19-44(18-5-6-22-49-25(2)46)20-21-45-37-30(16-17-31(40)35(36)37)29(38(45)39(47)48)11-9-23-50-34-13-7-10-26-24-27(41)14-15-28(26)34/h7,10,13-17,24H,4-6,8-9,11-12,18-23H2,1-3H3,(H,47,48) VMLMIPYHDLPWFQ-UHFFFAOYSA-N 577715 (rac)-12-(4-acetoxybutyl)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 121 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577715&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591267 474499875 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218258 CCc1c-2c(CCCN(CCCCOC(C)=O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C39H44ClFN4O5/c1-4-33-36-32(42-43(33)3)12-8-19-44(18-5-6-22-49-25(2)46)20-21-45-37-30(16-17-31(40)35(36)37)29(38(45)39(47)48)11-9-23-50-34-13-7-10-26-24-27(41)14-15-28(26)34/h7,10,13-17,24H,4-6,8-9,11-12,18-23H2,1-3H3,(H,47,48) VMLMIPYHDLPWFQ-UHFFFAOYSA-N 577715 (rac)-12-(4-acetoxybutyl)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 121 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577715&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591267 474499875 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218259 CCc1c-2c(CCCN(CCCCOC(C)=O)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C39H44ClFN4O5/c1-4-33-36-32(42-43(33)3)12-8-19-44(18-5-6-22-49-25(2)46)20-21-45-37-30(16-17-31(40)35(36)37)29(38(45)39(47)48)11-9-23-50-34-13-7-10-26-24-27(41)14-15-28(26)34/h7,10,13-17,24H,4-6,8-9,11-12,18-23H2,1-3H3,(H,47,48) VMLMIPYHDLPWFQ-UHFFFAOYSA-N 577715 (rac)-12-(4-acetoxybutyl)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 121 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577715&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591267 474499875 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218260 CCc1c-2c(CCCN(CCCCO)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C37H42ClFN4O4/c1-3-31-34-30(40-41(31)2)11-7-18-42(17-4-5-21-44)19-20-43-35-28(15-16-29(38)33(34)35)27(36(43)37(45)46)10-8-22-47-32-12-6-9-24-23-25(39)13-14-26(24)32/h6,9,12-16,23,44H,3-5,7-8,10-11,17-22H2,1-2H3,(H,45,46) NTVJBMGQNBWXBH-UHFFFAOYSA-N 577716 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-12-(4-hydroxybutyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 122 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577716&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591220 474499876 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218261 CCc1c-2c(CCCN(CCCCO)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C37H42ClFN4O4/c1-3-31-34-30(40-41(31)2)11-7-18-42(17-4-5-21-44)19-20-43-35-28(15-16-29(38)33(34)35)27(36(43)37(45)46)10-8-22-47-32-12-6-9-24-23-25(39)13-14-26(24)32/h6,9,12-16,23,44H,3-5,7-8,10-11,17-22H2,1-2H3,(H,45,46) NTVJBMGQNBWXBH-UHFFFAOYSA-N 577716 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-12-(4-hydroxybutyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 122 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577716&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591220 474499876 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218262 CCc1c-2c(CCCN(CCCCO)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C37H42ClFN4O4/c1-3-31-34-30(40-41(31)2)11-7-18-42(17-4-5-21-44)19-20-43-35-28(15-16-29(38)33(34)35)27(36(43)37(45)46)10-8-22-47-32-12-6-9-24-23-25(39)13-14-26(24)32/h6,9,12-16,23,44H,3-5,7-8,10-11,17-22H2,1-2H3,(H,45,46) NTVJBMGQNBWXBH-UHFFFAOYSA-N 577716 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-12-(4-hydroxybutyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 122 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577716&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591220 474499876 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218263 CCc1c-2c(CCCN(CC(F)(F)C(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H36ClF5N4O3/c1-3-28-31-27(43-44(28)2)9-5-15-45(20-36(41,42)35(39)40)16-17-46-32-25(13-14-26(37)30(31)32)24(33(46)34(47)48)8-6-18-49-29-10-4-7-21-19-22(38)11-12-23(21)29/h4,7,10-14,19,35H,3,5-6,8-9,15-18,20H2,1-2H3,(H,47,48) DRNIXHSDQJHFDF-UHFFFAOYSA-N 577717 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-12-(2,2,3,3-tetrafluoropropyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 123 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 5.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577717&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591231 474499877 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218264 CCc1c-2c(CCCN(CC(F)(F)C(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H36ClF5N4O3/c1-3-28-31-27(43-44(28)2)9-5-15-45(20-36(41,42)35(39)40)16-17-46-32-25(13-14-26(37)30(31)32)24(33(46)34(47)48)8-6-18-49-29-10-4-7-21-19-22(38)11-12-23(21)29/h4,7,10-14,19,35H,3,5-6,8-9,15-18,20H2,1-2H3,(H,47,48) DRNIXHSDQJHFDF-UHFFFAOYSA-N 577717 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-12-(2,2,3,3-tetrafluoropropyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 123 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577717&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591231 474499877 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218265 CCc1c-2c(CCCN(CC(F)(F)C(F)F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H36ClF5N4O3/c1-3-28-31-27(43-44(28)2)9-5-15-45(20-36(41,42)35(39)40)16-17-46-32-25(13-14-26(37)30(31)32)24(33(46)34(47)48)8-6-18-49-29-10-4-7-21-19-22(38)11-12-23(21)29/h4,7,10-14,19,35H,3,5-6,8-9,15-18,20H2,1-2H3,(H,47,48) DRNIXHSDQJHFDF-UHFFFAOYSA-N 577717 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-12-(2,2,3,3-tetrafluoropropyl)-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,4]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 123 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human 19000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577717&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591231 474499877 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218266 CCc1c-2c(CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) MENDZIZPQZNJFU-UHFFFAOYSA-N 577718 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 124 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577718&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591121 474499878 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218267 CCc1c-2c(CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) MENDZIZPQZNJFU-UHFFFAOYSA-N 577718 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 124 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577718&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591121 474499878 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218268 CCc1c-2c(CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H33ClFN3O4/c1-3-27-30-26(36-37(27)2)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) MENDZIZPQZNJFU-UHFFFAOYSA-N 577718 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2-methyl-2,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 124 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577718&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591121 474499878 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218269 CCc1nn(C)c2CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) UHVHAZALLKRBMD-UHFFFAOYSA-N 577719 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-1-methyl-1,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 125 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577719&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591078 474499879 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218270 CCc1nn(C)c2CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) UHVHAZALLKRBMD-UHFFFAOYSA-N 577719 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-1-methyl-1,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 125 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577719&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591078 474499879 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218271 CCc1nn(C)c2CCCOCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c(-c12)c34 InChI=1S/C33H33ClFN3O4/c1-3-26-30-27(37(2)36-26)9-6-16-41-18-15-38-31-24(13-14-25(34)29(30)31)23(32(38)33(39)40)8-5-17-42-28-10-4-7-20-19-21(35)11-12-22(20)28/h4,7,10-14,19H,3,5-6,8-9,15-18H2,1-2H3,(H,39,40) UHVHAZALLKRBMD-UHFFFAOYSA-N 577719 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-1-methyl-1,10,11,13,14,15-hexahydropyrazolo[4′,3′:7,8][1,4]oxazacycloundecino[6,5,4-hi]indole-8-carboxylic acid::US11478451, Example 125 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577719&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591078 474499879 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218272 CCc1c-2c(CN(C)CC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)19-34(37,38)14-15-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) YZYMZHBSKWEGRE-UHFFFAOYSA-N 577720 (rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium-8-carboxylate::US11478451, Example 126::US11478451, Example 127::US11478451, Example 128 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.20 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577720&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591333 474499880 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218273 CCc1c-2c(CN(C)CC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)19-34(37,38)14-15-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) YZYMZHBSKWEGRE-UHFFFAOYSA-N 577720 (rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium-8-carboxylate::US11478451, Example 126::US11478451, Example 127::US11478451, Example 128 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human 10000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577720&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591333 474499880 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218274 CCc1c-2c(CN(C)CC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)19-34(37,38)14-15-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) YZYMZHBSKWEGRE-UHFFFAOYSA-N 577720 (rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium-8-carboxylate::US11478451, Example 126::US11478451, Example 127::US11478451, Example 128 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577720&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591333 474499880 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218275 CCc1c-2c(CN(C)CC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)19-34(37,38)14-15-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) YZYMZHBSKWEGRE-UHFFFAOYSA-N 577720 (rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium-8-carboxylate::US11478451, Example 126::US11478451, Example 127::US11478451, Example 128 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.00 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577720&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591333 474499880 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218276 CCc1c-2c(CN(C)CC(F)(F)CCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)19-34(37,38)14-15-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) YZYMZHBSKWEGRE-UHFFFAOYSA-N 577720 (rac)-4-Chloro-3-ethyl-12,12-difluoro-7-{3-[(6-fluoro-1-naphthyl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indol-14-ium-8-carboxylate::US11478451, Example 126::US11478451, Example 127::US11478451, Example 128 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577720&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591333 474499880 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218277 CCc1c-2c(CN(C)CCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)15-14-34(37,38)19-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) JNJJNEKBXXZGON-UHFFFAOYSA-N 577723 (rac)-4-chloro-3-ethyl-11,11-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 129 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577723&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591320 474499881 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218278 CCc1c-2c(CN(C)CCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)15-14-34(37,38)19-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) JNJJNEKBXXZGON-UHFFFAOYSA-N 577723 (rac)-4-chloro-3-ethyl-11,11-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 129 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577723&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591320 474499881 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218279 CCc1c-2c(CN(C)CCC(F)(F)Cn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C34H34ClF3N4O3/c1-4-27-30-26(39-41(27)3)18-40(2)15-14-34(37,38)19-42-31-24(12-13-25(35)29(30)31)23(32(42)33(43)44)8-6-16-45-28-9-5-7-20-17-21(36)10-11-22(20)28/h5,7,9-13,17H,4,6,8,14-16,18-19H2,1-3H3,(H,43,44) JNJJNEKBXXZGON-UHFFFAOYSA-N 577723 (rac)-4-chloro-3-ethyl-11,11-difluoro-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2,14-dimethyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 129 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577723&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591320 474499881 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218280 CCc1c-2c(CNCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-3-27-30-26(37-38(27)2)19-36-15-4-5-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18,36H,3-5,7,9,15-17,19H2,1-2H3,(H,40,41) GQUYSLKMKGCSSK-UHFFFAOYSA-N 577724 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 130 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.40 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577724&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591084 474499882 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218281 CCc1c-2c(CNCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-3-27-30-26(37-38(27)2)19-36-15-4-5-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18,36H,3-5,7,9,15-17,19H2,1-2H3,(H,40,41) GQUYSLKMKGCSSK-UHFFFAOYSA-N 577724 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 130 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577724&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591084 474499882 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218282 CCc1c-2c(CNCCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C33H34ClFN4O3/c1-3-27-30-26(37-38(27)2)19-36-15-4-5-16-39-31-24(13-14-25(34)29(30)31)23(32(39)33(40)41)9-7-17-42-28-10-6-8-20-18-21(35)11-12-22(20)28/h6,8,10-14,18,36H,3-5,7,9,15-17,19H2,1-2H3,(H,40,41) GQUYSLKMKGCSSK-UHFFFAOYSA-N 577724 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 130 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577724&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591084 474499882 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218283 CCc1c-2c(CN(CCOC)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-4-30-33-29(39-40(30)2)22-41(18-20-45-3)16-5-6-17-42-34-27(14-15-28(37)32(33)34)26(35(42)36(43)44)10-8-19-46-31-11-7-9-23-21-24(38)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,43,44) FSDBDUGRFNHSHC-UHFFFAOYSA-N 577725 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(2-methoxyethyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 131::US11478451, Example 132 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.10 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577725&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591322 474499883 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218284 CCc1c-2c(CN(CCOC)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-4-30-33-29(39-40(30)2)22-41(18-20-45-3)16-5-6-17-42-34-27(14-15-28(37)32(33)34)26(35(42)36(43)44)10-8-19-46-31-11-7-9-23-21-24(38)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,43,44) FSDBDUGRFNHSHC-UHFFFAOYSA-N 577725 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(2-methoxyethyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 131::US11478451, Example 132 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577725&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591322 474499883 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218285 CCc1c-2c(CN(CCOC)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-4-30-33-29(39-40(30)2)22-41(18-20-45-3)16-5-6-17-42-34-27(14-15-28(37)32(33)34)26(35(42)36(43)44)10-8-19-46-31-11-7-9-23-21-24(38)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,43,44) FSDBDUGRFNHSHC-UHFFFAOYSA-N 577725 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(2-methoxyethyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 131::US11478451, Example 132 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577725&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591322 474499883 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218286 CCc1c-2c(CN(CCOC)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-4-30-33-29(39-40(30)2)22-41(18-20-45-3)16-5-6-17-42-34-27(14-15-28(37)32(33)34)26(35(42)36(43)44)10-8-19-46-31-11-7-9-23-21-24(38)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,43,44) FSDBDUGRFNHSHC-UHFFFAOYSA-N 577725 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(2-methoxyethyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 131::US11478451, Example 132 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 23.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577725&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591322 474499883 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218287 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCOC)nn1C InChI=1S/C37H40ClFN4O6/c1-4-30-33-29(40-41(30)2)22-42(37(46)49-20-19-47-3)16-5-6-17-43-34-27(14-15-28(38)32(33)34)26(35(43)36(44)45)10-8-18-48-31-11-7-9-23-21-24(39)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,44,45) VNVHSUQCALEXSI-UHFFFAOYSA-N 577727 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-[(2-methoxyethoxy)carbonyl]-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 134 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577727&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591307 474499884 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218288 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCOC)nn1C InChI=1S/C37H40ClFN4O6/c1-4-30-33-29(40-41(30)2)22-42(37(46)49-20-19-47-3)16-5-6-17-43-34-27(14-15-28(38)32(33)34)26(35(43)36(44)45)10-8-18-48-31-11-7-9-23-21-24(39)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,44,45) VNVHSUQCALEXSI-UHFFFAOYSA-N 577727 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-[(2-methoxyethoxy)carbonyl]-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 134 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577727&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591307 474499884 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218289 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCOC)nn1C InChI=1S/C37H40ClFN4O6/c1-4-30-33-29(40-41(30)2)22-42(37(46)49-20-19-47-3)16-5-6-17-43-34-27(14-15-28(38)32(33)34)26(35(43)36(44)45)10-8-18-48-31-11-7-9-23-21-24(39)12-13-25(23)31/h7,9,11-15,21H,4-6,8,10,16-20,22H2,1-3H3,(H,44,45) VNVHSUQCALEXSI-UHFFFAOYSA-N 577727 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-[(2-methoxyethoxy)carbonyl]-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 134 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577727&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591307 474499884 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218290 CCc1c-2c(CN(CCC3CCOCC3)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C40H46ClFN4O4/c1-3-34-37-33(43-44(34)2)25-45(20-15-26-16-22-49-23-17-26)18-4-5-19-46-38-31(13-14-32(41)36(37)38)30(39(46)40(47)48)9-7-21-50-35-10-6-8-27-24-28(42)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,47,48) GFBBKAVUWIQWMC-UHFFFAOYSA-N 577728 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 135::US11478451, Example 137 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 1.70 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577728&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591180 474499885 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218291 CCc1c-2c(CN(CCC3CCOCC3)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C40H46ClFN4O4/c1-3-34-37-33(43-44(34)2)25-45(20-15-26-16-22-49-23-17-26)18-4-5-19-46-38-31(13-14-32(41)36(37)38)30(39(46)40(47)48)9-7-21-50-35-10-6-8-27-24-28(42)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,47,48) GFBBKAVUWIQWMC-UHFFFAOYSA-N 577728 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 135::US11478451, Example 137 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577728&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591180 474499885 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218292 CCc1c-2c(CN(CCC3CCOCC3)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C40H46ClFN4O4/c1-3-34-37-33(43-44(34)2)25-45(20-15-26-16-22-49-23-17-26)18-4-5-19-46-38-31(13-14-32(41)36(37)38)30(39(46)40(47)48)9-7-21-50-35-10-6-8-27-24-28(42)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,47,48) GFBBKAVUWIQWMC-UHFFFAOYSA-N 577728 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 135::US11478451, Example 137 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577728&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591180 474499885 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218293 CCc1c-2c(CN(CCC3CCOCC3)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C40H46ClFN4O4/c1-3-34-37-33(43-44(34)2)25-45(20-15-26-16-22-49-23-17-26)18-4-5-19-46-38-31(13-14-32(41)36(37)38)30(39(46)40(47)48)9-7-21-50-35-10-6-8-27-24-28(42)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,47,48) GFBBKAVUWIQWMC-UHFFFAOYSA-N 577728 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-[2-(oxan-4-yl)ethyl]-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 135::US11478451, Example 137 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 52.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577728&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591180 474499885 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218294 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCC2CCOCC2)nn1C InChI=1S/C41H46ClFN4O6/c1-3-34-37-33(44-45(34)2)25-46(41(50)53-23-17-26-15-21-51-22-16-26)18-4-5-19-47-38-31(13-14-32(42)36(37)38)30(39(47)40(48)49)9-7-20-52-35-10-6-8-27-24-28(43)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,48,49) ISUPITFQRXTUBF-UHFFFAOYSA-N 577730 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-{[2-(oxan-4-yl)ethoxy]carbonyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 138 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 3.60 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577730&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591321 474499886 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218295 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCC2CCOCC2)nn1C InChI=1S/C41H46ClFN4O6/c1-3-34-37-33(44-45(34)2)25-46(41(50)53-23-17-26-15-21-51-22-16-26)18-4-5-19-47-38-31(13-14-32(42)36(37)38)30(39(47)40(48)49)9-7-20-52-35-10-6-8-27-24-28(43)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,48,49) ISUPITFQRXTUBF-UHFFFAOYSA-N 577730 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-{[2-(oxan-4-yl)ethoxy]carbonyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 138 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577730&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591321 474499886 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218296 CCc1c-2c(CN(CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)C(=O)OCCC2CCOCC2)nn1C InChI=1S/C41H46ClFN4O6/c1-3-34-37-33(44-45(34)2)25-46(41(50)53-23-17-26-15-21-51-22-16-26)18-4-5-19-47-38-31(13-14-32(42)36(37)38)30(39(47)40(48)49)9-7-20-52-35-10-6-8-27-24-28(43)11-12-29(27)35/h6,8,10-14,24,26H,3-5,7,9,15-23,25H2,1-2H3,(H,48,49) ISUPITFQRXTUBF-UHFFFAOYSA-N 577730 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-14-{[2-(oxan-4-yl)ethoxy]carbonyl}-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 138 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577730&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591321 474499886 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218297 CCc1c-2c(CN(CCCO)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-3-30-33-29(39-40(30)2)22-41(17-8-19-43)16-4-5-18-42-34-27(14-15-28(37)32(33)34)26(35(42)36(44)45)10-7-20-46-31-11-6-9-23-21-24(38)12-13-25(23)31/h6,9,11-15,21,43H,3-5,7-8,10,16-20,22H2,1-2H3,(H,44,45) LKHKVFNADZMDJC-UHFFFAOYSA-N 577731 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(3-hydroxypropyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 139 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 2.00 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577731&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591171 474499887 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218298 CCc1c-2c(CN(CCCO)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-3-30-33-29(39-40(30)2)22-41(17-8-19-43)16-4-5-18-42-34-27(14-15-28(37)32(33)34)26(35(42)36(44)45)10-7-20-46-31-11-6-9-23-21-24(38)12-13-25(23)31/h6,9,11-15,21,43H,3-5,7-8,10,16-20,22H2,1-2H3,(H,44,45) LKHKVFNADZMDJC-UHFFFAOYSA-N 577731 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(3-hydroxypropyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 139 Bcl-2-like protein 1 [1-212]/Bad BH3 Peptide Human >20000 US Patent 10.7270/Q2NG4TXW aid1806934 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=260&target=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577731&enzyme=Bcl-2-like+protein+1+%5B1-212%5D%2FBad+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591171 474499887 2 MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNR 1PQ0,1PQ1,1R2D,2B48,2ME8,2ME9,2MEJ,3IHC,3IIH,4HNJ,6HJL,7CA4 Bcl-2-like protein 1 B2CL1_HUMAN Q07817 E1P5L6 Q5CZ89 Q5TE65 Q92976 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218299 CCc1c-2c(CN(CCCO)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C36H40ClFN4O4/c1-3-30-33-29(39-40(30)2)22-41(17-8-19-43)16-4-5-18-42-34-27(14-15-28(37)32(33)34)26(35(42)36(44)45)10-7-20-46-31-11-6-9-23-21-24(38)12-13-25(23)31/h6,9,11-15,21,43H,3-5,7-8,10,16-20,22H2,1-2H3,(H,44,45) LKHKVFNADZMDJC-UHFFFAOYSA-N 577731 (rac)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(3-hydroxypropyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid::US11478451, Example 139 Apoptosis regulator Bcl-2/Bcl2-associated agonist of cell death [103-127,M117N] Human >20000 US Patent 10.7270/Q2NG4TXW aid1806935 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=180&target=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577731&enzyme=Apoptosis+regulator+Bcl-2%2FBcl2-associated+agonist+of+cell+death+%5B103-127%2CM117N%5D&column=ki&startPg=0&Increment=50&submit=Search 142591171 474499887 2 MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK 2XA0,5JSN Apoptosis regulator Bcl-2 BCL2_HUMAN P10415 C9JHD5 P10416 Q13842 Q16197 NLWAAQRYGRELRRNSDEFVDSFKK Bcl2-associated agonist of cell death BAD_HUMAN Q92934 O14803 Q6FH21 1218300 CCc1c-2c(CN(CCC(C)(C)O)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C38H44ClFN4O4/c1-5-31-34-30(41-42(31)4)23-43(20-17-38(2,3)47)18-6-7-19-44-35-28(15-16-29(39)33(34)35)27(36(44)37(45)46)11-9-21-48-32-12-8-10-24-22-25(40)13-14-26(24)32/h8,10,12-16,22,47H,5-7,9,11,17-21,23H2,1-4H3,(H,45,46) QFHUAJLMTZLYGS-UHFFFAOYSA-N 577732 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(3-hydroxy-3-methylbutyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 2)::US11478451, Example 141::US11478451, Example 143 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 15.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577732&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591173 474499888 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589 1218301 CCc1c-2c(CN(CCC(C)(C)O)CCCCn3c(C(O)=O)c(CCCOc4cccc5cc(F)ccc45)c4ccc(Cl)c-2c34)nn1C InChI=1S/C38H44ClFN4O4/c1-5-31-34-30(41-42(31)4)23-43(20-17-38(2,3)47)18-6-7-19-44-35-28(15-16-29(39)33(34)35)27(36(44)37(45)46)11-9-21-48-32-12-8-10-24-22-25(40)13-14-26(24)32/h8,10,12-16,22,47H,5-7,9,11,17-21,23H2,1-4H3,(H,45,46) QFHUAJLMTZLYGS-UHFFFAOYSA-N 577732 4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-14-(3-hydroxy-3-methylbutyl)-2-methyl-10,11,12,13,14,15-hexahydro-2H-pyrazolo[3′,4′:8,9][1,6]diazacycloundecino[10,11,1-hi]indole-8-carboxylic acid (Enantiomer 2)::US11478451, Example 141::US11478451, Example 143 Induced myeloid leukemia cell differentiation protein Mcl-1 [173-321]/Noxa BH3 Peptide Human 62.0 US Patent 10.7270/Q2NG4TXW aid1806933 US11478451 Thede, K; Mengel, A; Christ, C; Kuhnke, J; Johannes, SA; Buchgraber, P; Klar, U; Rauh, U; Kaulfuss, S; Fernandez-Montalvan, AE; Werbeck, N; Moenning, U; Nowak-Reppel, K; Lemke, C; Serrano-Wu, MH; McKinney, D; Fitzgerald, M; Nasveschuk, C; Lazarski, K; Ferrara, SJ; Furst, L; Wei, G; McCarren, PR; Harvey, RA; Payne, D; Pesnot, T; Wilson, C 10/25/2022 12/30/2022 Bayer Aktiengesellschaft; Bayer Pharma Aktiengesellschaft; The Broad Institute, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=577732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=197&target=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=577732&enzyme=Induced+myeloid+leukemia+cell+differentiation+protein+Mcl-1+%5B173-321%5D%2FNoxa+BH3+Peptide&column=ki&startPg=0&Increment=50&submit=Search 142591173 474499888 3 ELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV 7XGE,8H7B,8IQM Induced myeloid leukemia cell differentiation protein Mcl-1 MCL1_HUMAN Q07820 B2R6B2 D3DV03 D3DV04 Q9HD91 Q9NRQ3 Q9NRQ4 Q9UHR7 Q9UHR8 Q9UHR9 Q9UNJ1 MASVQLQNVTKAWGEVVVSKDINLDIHEGEFVVFVGPSGCGKSTLLRMIAGLETITSGDLFIGEKRMNDTPPAERGVGMVFQSYALYPHLSVAENMSFGLKLAGAKKEVINQRVNQVAEVLQLAHLLDRKPKALSGGQRQRVAIGRTLVAEPSVFLLDEPLSNLDAALRVQMRIEISRLHKRLGRTMIYVTHDQVEAMTLADKIVVLDAGRVAQVGKPLELYHYPADRFVAGFIGSPKMNFLPVKVTATAIDQVQVELPMPNRQQVWLPVESRDVQVGANMSLGIRPEHLLPSDIADVILEGEVQVVEQLGNETQIHIQIPSIRQNLVYRQNDVVLVEEGATFAIGLPPERCHLFREDGTACRRLHKEPGV 1Q12,1Q1B,1Q1E,2AWN,2AWO,3FH6,3PUV,3PUW,3PUX,3PUY,3PUZ,3PV0,3RLF,4JBW,4KHZ,4KI0 Maltose/maltodextrin import ATP-binding protein MalK MALK_ECOLI P68187 P02914 Q2M6R9 Q47348 PAELEVEVATQLRRFGDKLNFRQKLL Phorbol-12-myristate-13-acetate-induced protein 1 APR_HUMAN Q13794 B2R4T7 Q8N589